Consent for clinical genetic testing in Norway

With the increased utilization of genomic sequencing in the clinical context in Norway, practical and ethical issues in the development of the content and process of informed consent (IC) are emerging.

This document aims to interpret high-level regulations through the lens of clinical NGS and to provide a list of resources to aid labs in developing high quality diagnostics, ensuring compliance with applicable regulations, and delivering a high standard of care within their organizations.